/R E P E A T -- Media Advisory - Innovative Medicines Canada to Publish Results of 2016 Access to Medicines Report/

OTTAWA, May 20, 2016 /CNW/ - Innovative Medicines Canada will publish the results of their 2016 report on access to medicines in Canadian public drug plans, detailing the significant delays Canadians face in accessing medicines compared to international comparators at a press conference, with Executive Director, Communications Isabelle Robillard and Brett Skinner, Executive Director of Health and Economic Policy. Larry Taylor will also be present to explain the impact on patients suffering from diabetes.


Tuesday, May 24, 2016


10:00 am - 10:45 am


National Press Theatre

150 Wellington Street

Ottawa, Ontario K1A 0A8


About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.


SOURCE Innovative Medicines Canada

For further information: Heather Brennae, Media Relations, Telephone: 613-236-0455 ext. 527 , E-mail: hbrennae@imc-mnc.ca


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890